The Penlon ESO 2 Emergency Ventilator today received internationally recognised CE Mark approval for the treatment of COVID-19 patients
Penlon today announced that the Company received CE Mark approval for its ESO 2 Emergency Ventilator for the treatment of COVID-19 patients. For the past three months, Penlon has been working as part of the ‘VentilatorChallengeUK’ consortium to mass-produce thousands of ESO 2 Emergency Ventilators for the NHS in the fight against COVID-19. During that period working was going on to ensure that the ESO 2 would be available outside the UK.
Using its ventilation expertise, Penlon rapidly developed the ESO 2 Emergency Ventilator, based on the existing AV-S anaesthesia ventilator platform. The purpose of the ESO 2 is to save lives by ventilating the sickest patients until they are strong enough to be transferred to one of the limited number of ICU ventilators available for recovery.
With international CE certification, the ESO 2 Emergency Ventilator will soon be available through Penlon’s global distribution network.
Mary Ryan, Penlon’s Director Quality Assurance and Regulatory Affairs said:
Ventilator Challenge UK Consortium presented with a President’s Special Award from the Royal Academy of Engineering for their part in tackling COVID-19.
VentilatorChallengeUK marks the end of the consortium after delivering 13,437 ventilators to the NHS
Tim Rance, Production Manager at Penlon, talks about the ESO 2 Emergency Ventilator, the VentilatorChallengeUK (VCUK) consortium and working at Penlon during the coronavirus pandemic.
Paul Merrick, Production Engineering Manager at Penlon, talks about the ESO 2 Emergency Ventilator, the VentilatorChallengeUK (VCUK) consortium and working at Penlon during the coronavirus pandemic.